IQVIA Core Diabetes Model

Real-World Evidence

IQVIA offers several real-world evidence solutions

The use of patient-level data can add depth and granularity to analyses that support the demonstration of a product value.

  • To identify unmeet clinical need in routine care and design IQVIA CORE Diabetes Model simulations that reflect routine clinical practice in a given country;
  • To evaluate effectiveness of drugs and use this information as input for cost-effectiveness analyses;
  • To determine the effectiveness of a drug in patient populations not evaluated in clinical trials;
  • To use demographic, clinical and medication data for diabetic sub populations to identify target patient groups for early stage cost effectiveness analysis;
  • To monitor the uptake and safety of a drug in real-life settings to support discussions with payers and regulatory authorities.

Covering more than 300 million patient lives, LifeLink data assets can provide diabetes insights in several markets. Assets include:

  • Health plan claims data
  • Longitudinal prescription data
  • Electronic medical record
  • Hospital Treatment Insight
  • Longitudinal patient databases

Of particular interest to researchers in diabetes is our French diabetes cohort, which was specifically designed to answer questions from the diabetes community in type 1 and type 2 diabetes.

Click here to learn more about IQVIA patient-level data assets.

Click here to access your v9.5 CDM account.

Click here to access your v9.0 CDM account.

Find out how our team can help.

Additional Information

IQVIA CORE Diabetes Model is an IQVIA online application.
Click here for the HEOR & Real-World Evidence homepage.
This site is only supported with latest internet browser technology (HTML5, CSS3 & Jquery inside).

Privacy   |   Terms of Use    Copyright © 2017 IQVIA Incorporated. All rights reserved.